Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05916092
Other study ID # SPARTAN-001
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date October 19, 2023
Est. completion date July 2026

Study information

Verified date February 2024
Source CornerLoc
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A prospective study on the use of the TransLoc 3D SI Joint Fusion System for patients with sacroiliac joint disruptions or degenerative sacroiliitis.


Description:

Multicenter, prospective, post-market surveillance study on the TransLoc 3D Sacroiliac Joint Fusion System including two treatment arms: 1) Lateral-Oblique TransLoc 3D Screw(s), 2) Lateral Oblique TransLoc 3D Screw with Posterior Device (Hybrid). Data from this post-market study will be used to support knowledge of clinical efficacy and improvement with the use of TransLoc 3D Sacroiliac Joint Fusion System.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 240
Est. completion date July 2026
Est. primary completion date December 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Subjects meeting all of the following inclusion criteria by the end of the screening phase should be considered for admission to the study: - Age 18-85* (*Over 85 is allowed with H&P assessment screening upon approval by Medical Monitor); - Absent condition of high-risk surgical candidate (see training manual for definition); - Patient has lower back pain with a confirmed diagnosis of sacroiliac joint disruption or degenerative sacroiliitis for a period of >6 months and who has not responded to optimal conservative care (PT or prescribed HEP, optimal medical management including NSAIDs); - Diagnosis of sacroiliac joint disruption or degenerative sacroiliitis based on ALL of the following: a. Patient has pain at or close to the posterior superior iliac spine (PSIS) with possible radiation into buttocks, posterior thigh or groin and can point with a single finger to the location of pain (Fortin Finger Test), and b. at least three positive findings with provocative maneuvers (FABER, Gaenslen, Thigh Thrust or Posterior Shear, SI Compression, SI Distraction, and Yeoman Test); - Patient has a diagnostic SIJ injection (SIJI) that provided a minimum of 75% relief of primary (index) pain with the diagnostic SIJI on two separate occasions; - Patient meets Medicare and payer requirements for medical necessity, see detailed requirements in training manual; - SI joint disruption: Asymmetric SI joint widening on X-ray or CT scan or degenerative sacroiliitis with radiographic evidence of SIJ degeneration as evidenced on CT or X-ray; - SI joint pain or instability with or without prior lumbar/lumbosacral surgery; - Baseline Oswestry Disability Index (ODI) score of at least 30%; - Baseline SI joint pain score of at least 60 on 0-100mm visual analog scale (or at least a 6 on NRS); - Patient has the necessary mental capacity to participate and is physically able to comply with study protocol requirements; - Failed SIJ fusion revisions can be included if all other inclusion criteria are met; - Patient must be able to communicate with study personnel via phone, text, or email; - PI must confirm women of childbearing years are not pregnant or plan to become pregnant prior to surgery; - Cardiac Clearance for patients with diagnosis of cardiac disease; - Patient has signed study-specific informed consent form. Exclusion Criteria: - Patient will not be entered into the study if they meet one of the following criteria: - Current severe back pain due to other causes, such as lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, lumbar radicular pain that extends beyond the mid-thigh, and lumbar vertebral body fracture; - SIJ pain secondary to inflammatory conditions or other known sacroiliac pathology such as: Sacral dysplasia, Inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA-associated spondylo-arthropathy), Tumor or infection in the SI joint, Acute fracture or Crystal arthropathy; - History of recent (<1 year) major trauma to pelvis (MVA or significant accident that results in acute injury to pelvis requiring hospitalization or surgery); - Previously diagnosed osteoporosis (defined as prior T-score <-2.5 or history of osteoporotic fracture). If patient meets the osteoporosis screening criteria identified by the National Osteoporosis Foundation, they should be screened for osteoporosis with DEXA; - Autoimmune - patient who is currently not maintained on a medication regimen for treatment, and not stable (<6 months without exacerbation); - Any condition or anatomy that makes treatment with the TransLoc 3D Sacroiliac Joint Fusion System infeasible; - Current local or systemic infection that raises the risk of surgery; - Patient currently receiving disability remuneration, and/or involved in injury litigation; - Patient is undergoing treatment under Workman's Compensation under a claim or injury greater than 1 year; - Patient is participating in an investigational study or has been involved in an investigational study within 3 months prior to evaluation for participation; - Known to be pregnant, suspected pregnant, or planning to be pregnant prior to SIJ surgery; - Patient is a prisoner or a ward of the state; - Known or suspected drug or alcohol abuse; - Known allergy to titanium or titanium alloys; - Diagnosed psychiatric disease (e.g., schizophrenia, major depression, personality disorders) that is not well controlled for a minimum of two years and could interfere with study participation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TransLoc 3D
TransLoc 3D SI Joint Fusion System

Locations

Country Name City State
United States NY Spine and Pain Specialists Port Jefferson Station New York

Sponsors (1)

Lead Sponsor Collaborator
CornerLoc

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical improvement at 12 months defined by a composite score of functional status, pain, and safety events. Functional improvement and pain score have long been the standard for SI joint improvement measures. Multiple functional improvement scales will be assessed throughout the study. 12 months
Primary Absence of Serious Adverse Events (SAEs) Demonstrate safety as defined by Serious Adverse Events (SAEs). From the time informed consent is signed through 12 months.
Secondary Absence of study-related adverse events Evaluate any study-related adverse events for the duration of the study. 6 months, 12 months
See also
  Status Clinical Trial Phase
Terminated NCT03940287 - Muscle Energy Technique and Kinesiotaping in Mechanical Sacroiliac Joint Dysfunction N/A
Recruiting NCT06227637 - Local Muscle Vibration Versus Muscle Energy Technique In Sacroiliac Joint Dysfunction N/A
Completed NCT04790500 - Effects Of Muscle Energy Technique Versus Mobilization N/A
Completed NCT06099860 - Therapeutic Impact of KT Along With BT in Patients With Chronic Low Back Pain of Sacroiliac Joint Dysfunction N/A
Completed NCT06062459 - Synergistic Benefits of MCE and BT in Sacroiliac Joint Dysfunction: A Randomized Controlled Trial N/A
Completed NCT05479266 - Comparison of Muscle Energy Techniques and Myofascial Release on Low Back Pain Due to Sacroiliac Joint Dysfunction N/A
Recruiting NCT05870488 - iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction Phase 4
Recruiting NCT06442124 - The Effect of BMI on Gluteus Maximum Activity in Adulthood With Sacroiliac Dysfunction
Completed NCT05855304 - Comparison Of The Sacroiliac Manipulation And Kinesiological Tape In Basketball Players N/A
Recruiting NCT06268704 - Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection Phase 4
Completed NCT05786118 - The Effects of Sacroiliac Joint Dysfunction on Gait and Disability
Completed NCT00649753 - Algometer and Category II Pelvic Blocking and Cranial Protocol N/A
Completed NCT04824534 - Motion Analysis in Sacroiliac Joint Dysfunction
Not yet recruiting NCT05404984 - Effects of Core Stabilization Exercises With and Without Dry Cupping in Patients With Sacroiliac Joint Dysfunction N/A
Recruiting NCT06442540 - Effects of Intra Muscular Electrotherapy Combined With Manipulative Therapy in Patients With Sacral Torsion N/A
Completed NCT05018780 - Muscle Energy Techniques and Sacral Manipulation on Pain, Functional Disability and Quality of Life N/A
Active, not recruiting NCT02074761 - Evolusion Study Using the Zyga SImmetry Sacroiliac Joint Fusion System
Completed NCT04555083 - Association Between Chronic Ankle Instability and Sacroiliac Joint Dysfunction
Completed NCT03965507 - The Prevalence Of Sacroiliac Joint Dysfunction In Patients With Lumbar Disc Hernia
Enrolling by invitation NCT05712850 - Clinical Outcome and Fusion Results Using the SiJoin® Transfixing Sacroiliac Fusion Device